Dilated Cardiomyopathy - Pipeline Review, H2 2014, New Report Launched
Dilated Cardiomyopathy - Pipeline Review, H2 2014 report provides comprehensive information on the therapeutic development for Dilated Cardiomyopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dilated Cardiomyopathy and special features on late-stage and discontinued projects.
View full press release